Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of Angina

Adding ranolazine to the treatment regimen of patients with poorly controlled angina was associated with lower rates of revascularization and lower total costs of care than for comparable patients, differences both statistically and clinically relevant.